Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3688-3693

  Munoz, Marina ^a,b,c   Camargo, Milena ^a,b   Leon, Sara C Soto De ^a,b   Sanchez, Ricardo ^a,c   Pineda Peña, Andrea C ^b,d   Perez Prados, Antonio ^e   Patarroyo, Manuel E ^a,c   Patarroyo, Manuel A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^e PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; CERVIX UTERI; DNA PRIMERS; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINE; VIROLOGY;

EID: 84886452411     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01302-13     Document Type: Article

References (34)

1. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB.2000.Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.Ann. Intern. Med.132:810-819.
2. Rositch AF, Gatuguta A, Choi RY, Guthrie BL, Mackelprang RD, Bosire R, Manyara L, Kiarie JN, Smith JS, Farquhar C.2012.Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya.PLoS One 7:e40766.doi:10.1371/journal.pone.0040766.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV.2002.The causal relation between human papillomavirus and cervical cancer.J. Clin. Pathol.55:244-265.
4. Gravitt PE.2011.The known unknowns of HPV natural history.J.Clin.Invest. 121:4593-4599.
5. Clarke B, Chetty R.2002.Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer.Mol.Pathol.55:19-24.
6. Jayshree RS, Sreenivas A, Tessy M, Krishna S.2009.Cell intrinsic and extrinsic factors in cervical carcinogenesis.Indian J.Med.Res.130:286-295.
7. Doorbar J.2006.Molecular biology of human papillomavirus infection and cervical cancer.Clin.Sci.110:525-541.
8. Denny LA, Franceschi S, de Sanjose S, Heard I, Moscicki AB, Palefsky J.2012.Human papillomavirus, human immunodeficiency virus and immunosuppression.Vaccine 30(Suppl 5):F168-F174.
9. Denny LA, Wright TC, Jr.2005.Human papillomavirus testing and screening.Best Pract.Res.Clin.Obstet.Gynaecol.19:501-515.
10. Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V.2009.Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices.J.Obstet. Gynaecol.29:583-589.
11. Daponte A, Tsezou A, Oikonomou P, Hadjichristodoulou C, Maniatis AN, Pournaras S, Messinis IE.2008.Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens.Clin.Microbiol.Infect.14:619-621.
12. Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, Van Damme P.2012.Detection of human papillomavirus DNA in urine: a review of the literature.Eur. J. Clin. Microbiol. Infect. Dis.31:627-640.
13. Cervantes J, Lema C, Hurtado L, Andrade R, Quiroga G, Garcia G, Torricos L, Zegarra L, Vera V, Panoso W, Arteaga R, Segurondo D, Romero F, Dulon A, Asturizaga D, Hurtado Gomez L, Sonoda S.2003.Prevalence of human papillomavirus infection in rural villages of the Bolivian Amazon.Rev. Inst. Med. Trop. Sao Paulo 45:131-135.
14. Lindeque BG.2005.Management of cervical premalignant lesions.Best Pract.Res.Clin.Obstet.Gynaecol.19:545-561.
15. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA.1986.Analysis of enzymatically amplified-globin and HLA-DQ DNA with allelespecific oligonucleotide probes.Nature 324:163-166.
16. Camargo M, Soto-De Leon S, Sanchez R, Munoz M, Vega E, Beltran M, Perez-Prados A, Patarroyo ME, Patarroyo MA.2011.Detection by PCR of human papillomavirus in Colombia: comparison of GP5-/6-and MY09/11 primer sets.J. Virol. Methods 178:68-74.
17. Munoz M, Camargo M, Soto-De Leon SC, Rojas-Villarraga A, Sanchez R, Jaimes C, Perez-Prados A, Patarroyo ME, Patarroyo MA.2012.The diagnostic performance of classical molecular tests used for detecting human papillomavirus.J. Virol. Methods 185:32-38.
18. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S.2007.Human papillomavirus and cervical cancer.Lancet 370:890-907.
19. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B.2004.Detection and typing of human papillomavirus by e6 nested multiplex PCR.J. Clin. Microbiol.42:3176-3184.
20. Camargo M, Soto-De Leon SC, Sanchez R, Perez-Prados A, Patarroyo ME, Patarroyo MA.2011.Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia.Ann.Epidemiol.21:204-213.
21. Zhou X-H, Obuchowski NA, McClish DK.2008.Methods for correcting imperfect standard bias.John Wiley & Sons, New York, NY.
22. Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A.2006.Accuracy of Papanicolaou test among HIV-infected women.Clin. Infect. Dis.42:562-568.
23. Alameda F, Bellosillo B, Fuste P, Musset M, Marinoso ML, Mancebo G, Lopez-Yarto MT, Carreras R, Serrano S.2007.Human papillomavirus detection in urine samples: an alternative screening method.J.Low.Genit.Tract.Dis.11:5-7.
24. Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chaturvedi AK, Slavinsky IJ, Clayton JL, Dumestre J, Hagensee ME.2002.Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women.J. Clin. Microbiol.40:3155-3161.
25. Jong E, Mulder JW, van Gorp EC, Wagenaar JK, Derksen J, Westerga J, Tol A, Smits PH.2008.The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIVinfected women.J. Clin. Virol.41:111-115.
26. Murthy NS, Mathew A.2000.Risk factors for pre-cancerous lesions of the cervix.Eur.J.Cancer Prev.9:5-14.
27. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M.2001.HPVco-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.Br.J.Cancer 84:1219-1226.
28. Moscicki AB, Schiffman M, Kjaer S, Villa LL.2006.Chapter 5: updating the natural history of HPV and anogenital cancer.Vaccine 24(Suppl 3):S42-S51.
29. Burd EM.2003.Human papillomavirus and cervical cancer.Clin.Microbiol.Rev. 16:1-17.
30. Zhang YX, Xiong Y, Gui XE, Chen SH, Rong YP, Cai HB.2011.Epidemiologic risk profile ofhumanpapillomavirus infections inhumanimmunodeficiency virus-positive Chinese women.Jpn.J. Infect. Dis.64:411-416.
31. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD.2007.A comparison of cervical and vaginal human papillomavirus.Sex.Transm.Dis.34:849-855.
32. Ferenczy A, Coutlee F, Franco E, Hankins C.2003.Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments.CMAJ 169:431-434.
33. Cicchetti DV, Feinstein AR.1990.High agreement but low kappa.II.Resolving the paradoxes.J.Clin.Epidemiol.43:551-558.
34. Stanczuk GA, Kay P, Allan B, Chirara M, Tswana SA, Bergstrom S, Sibanda EN, Williamson AL.2003.Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.J.Med.Virol.71:110-114.